Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2013 09:33 ET | Source: Biodel Inc.

CORRECTION -- Biodel Reports Positive Top-Line Results From Clinical Study of Ultra-Rapid-Acting Insulin Analog Candidates

DANBURY, Conn., Jan. 24, 2013 (GLOBE NEWSWIRE) -- In a release issued earlier today by Biodel Inc. (Nasdaq:BIOD), one reference to BIOD-238 should have been BIOD-250 in the fourth paragraph. The...
January 24, 2013 06:00 ET | Source: Biodel Inc.

Biodel Reports Positive Top-Line Results From Clinical Study of Ultra-Rapid-Acting Insulin Analog Candidates

BIOD-238 and BIOD-250 demonstrate a pharmacokinetic profile superior to Humalog® with ultra-rapid absorption and rapid declines from peak concentration BIOD-250 demonstrates injection...
December 18, 2012 06:00 ET | Source: Biodel Inc.

Biodel Reports Fourth Quarter Fiscal Year 2012 Financial Results

DANBURY, Conn., Dec. 18, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today reported financial results for the fourth fiscal quarter ended September 30, 2012. Highlights of fourth fiscal...
December 14, 2012 07:00 ET | Source: Biodel Inc.

Biodel to Report Fourth Quarter Fiscal Year 2012 Financial Results on December 18, 2012

DANBURY, Conn., Dec. 14, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) will issue its fourth quarter fiscal year 2012 financial results on December 18, 2012. Following the release of the...
December 06, 2012 16:00 ET | Source: Biodel Inc.

FDA Grants Orphan Drug Designation to Biodel's Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Population

DANBURY, Conn., Dec. 6, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today announced that the FDA has granted orphan drug designation for Biodel's 'glucagon' for the prevention of hypoglycemia...
September 24, 2012 06:30 ET | Source: Biodel Inc.

Biodel Awarded NIH Grant to Develop Glucagon Formulations for Use in Artificial Pancreas

DANBURY, Conn., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has...
August 08, 2012 16:35 ET | Source: Biodel Inc.

Biodel Reports Third Quarter Fiscal Year 2012 Financial Results

DANBURY, Conn., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today reported financial results for the third fiscal quarter ended June 30, 2012. Highlights since beginning of third...
August 01, 2012 06:00 ET | Source: Biodel Inc.

Biodel to Report Third Quarter Fiscal Year 2012 Financial Results on August 8, 2012

DANBURY, Conn., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) will issue its third quarter fiscal year 2012 financial results on August 8, 2012. Following the release of the...
June 11, 2012 17:00 ET | Source: Biodel Inc.

Biodel Announces Effectiveness of Reverse Stock Split

DANBURY, Conn., June 11, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today announced that its Board of Directors has approved a reverse split of its common stock (the "Reverse Stock Split") at...
January 20, 2012 07:00 ET | Source: Biodel Inc.

Committee for Orphan Medicinal Products Recommends Orphan Designation for Biodel's Stabilized Glucagon for the Treatment of Congenital Hyperinsulinism

DANBURY, Conn., Jan. 20, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today reported that the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP) has recommended...